FDA Drug Application (077833) for NADOLOL AND BENDROFLUMETHIAZIDE by IMPAX LABS

Back to FDA Applications sponsored by IMPAX LABS

Application Number077833
Product Number001
FormTABLET;ORAL
Dosage5MG;40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNADOLOL AND BENDROFLUMETHIAZIDE
Active IngredientBENDROFLUMETHIAZIDE; NADOLOL

Active IngredientCount
List of drugs with Active Ingredient BENDROFLUMETHIAZIDE5
List of drugs with Active Ingredient NADOLOL4


Back to FDA Applications sponsored by IMPAX LABS